Celsius Therapeutics

United States
Primghar, Iowa, United States, 02142

Company profile

Celsius Therapeutics company profile

Celsius Therapeutics is a biotechnology company that develops precision medicines for cancer and autoimmune disease patients. The company is a group of scientists, technologists, computational biologists, clinicians, and drug hunters who use single-cell genomics and machine learning analysis to find new drugs. Celsius Therapeutics was founded in 2018 and is headquartered in Cambridge, Massachusetts.

Business identity

Contact email
[email protected]
Phone number
857-776-7400
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2018-01-01, Year

Headquarters

Postal code
02142
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
M And A
Funding rounds
2
Total equity funding
$148M
Last funding
Series B / $83M / 2022-03-24
Last equity funding
Series B / $83M
Investors
11
Lead investors
2
Founders
5
Articles
20
Exited on
2024-06-27

Founders and investors

Founders

Aviv RegevChristoph LengauerJeffrey BluestoneRamnik XavierVijay Kuchroo

Lead investors

Casdin CapitalThird Rock Ventures

Investors

Casdin CapitalCatalio Capital ManagementGoogle VenturesS32Third Rock Ventures